MindBio Therapeutics Corp.
MBQIF
$0.36
-$0.12-25.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.38M | 1.58M | 770.60K | 1.03M | 62.70K |
| Depreciation & Amortization | -- | -- | 200.00 | -56.80K | -- |
| Other Operating Expenses | -- | -- | 17.10K | -- | -- |
| Total Operating Expenses | 1.38M | 1.58M | 787.90K | 975.70K | 62.70K |
| Operating Income | -1.38M | -1.58M | -787.90K | -975.70K | -62.70K |
| Income Before Tax | -1.41M | -1.59M | -790.00K | -919.30K | -591.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.41M | -1.59M | -790.00K | -919.30K | -591.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.90K | -500.00 | -300.00 | -3.30K | 800.00 |
| Net Income | -1.41M | -1.59M | -790.30K | -922.50K | -590.80K |
| EBIT | -1.38M | -1.58M | -787.90K | -975.70K | -62.70K |
| EBITDA | -- | -- | -787.70K | -975.70K | -62.70K |
| EPS Basic | -0.18 | -1.08 | -0.92 | -0.88 | -1.76 |
| Normalized Basic EPS | -0.11 | -0.67 | -0.58 | -0.74 | -0.18 |
| EPS Diluted | -0.18 | -1.08 | -0.92 | -0.88 | -1.76 |
| Normalized Diluted EPS | -0.11 | -0.25 | -0.58 | -0.74 | -0.18 |
| Average Basic Shares Outstanding | 8.04M | 1.48M | 858.40K | 1.04M | 336.40K |
| Average Diluted Shares Outstanding | 8.04M | 4.03M | 858.40K | 1.04M | 336.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |